NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
Back to search
Official data from USPTO
INEXELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
06/03/2025
Trademark type
Word
Nice classes
42, 44
Filing date
06/13/2024
Registration date
06/03/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Rennes, FR
Examiner
GOLDEN, JAMES B
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
S. V. (pessoa física)
Representatives
Pina Campagna Carter, DeLuca, and Farrell, LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development in the field of stem cellscell therapypersonalized medicine and biotechnology; pharmaceutical research and development in the field of cell therapy and personalized medicine; scientific laboratory services; scientific study and research in the field of activitytoxicitymetabolism and mechanism of action of molecules; provision of information related to scientific research in the field of cellscell therapypersonalized medicinepharmacologytoxicology and biotechnology; Research and development of cell therapy and personalized medicine products and treatments; Laboratory research services in the field of cell therapypersonalized medicinepharmacology and toxicology; Chemical research and development; Provision of information and data related to research and development in the field of cell therapypersonalized medicinepharmacology and toxicology; Biologicalclinical and medical research in the field of cell therapypersonalized medicinepharmacology and toxicology; Biologicalclinical and medical research in the field of cell therapypersonalized medicinepharmacology and toxicology; Chemicalbiologicalbacteriological and biochemical analysis services; Medical and scientific researchconducting clinical trials for others in the field of cell therapy and personalized medicine; provision of medical and scientific research information regarding the results of clinical trials in the field of cell therapy and personalized medicine; design and development of biological and chemical reagents and assays; Design and development of cellular modelscell linescell culturecell-based assays; Design and development of chemical and biological reagents for cell cultureproductionanalysissorting and processing; Consulting services related to the monitoring of medical or laboratory diagnostic protocolsconsulting services related to the calibration of scientific apparatus and instrumentsconsulting services relating to the calibration of medical or laboratory diagnostic devices and instrumentsconsulting services for the development of chemical and biological reagents; Scientific research services related to cellular modelscell linescell culturecell-based assays for the medical field; Scientific research services related to cellular products cellular modelscell linescell culturecell-based assays for toxicology and pharmacology studies
Class 44
Medical and biological analysis services relating to the treatment of people with cell therapy; providing medical information in the form of medical reports in the field of cell therapy and personalized medicine; Medical and biological information services in the field of cell therapy and personalized medicine; Public health advice on cell therapy and personalized medicine
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
05/14/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/06/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/06/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2025
DOCK
ASSIGNED TO EXAMINER
01/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2025
NWAP
NEW APPLICATION ENTERED
06/13/2024
Continuous trademark protection
Get notified about every new filing that threatens INEXELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.